Who owns ROPANC BIOPHARMA INC?
- Ticker: PPCB
- CUSIP Number: 74346n701
Tip: Access positions for across all investors
Analyze quarterly positions in Ropanc Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ropanc Biopharma stock
Who bought or sold ROPANC BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS Group | 183k | $19k | 100% | Mar 2026 |
|
| Jane Street | 143k | $15k | 100% | Mar 2026 |
|
| Marex Group | 68k | $7.2k | 4% | Mar 2026 |
|
| XTX Topco | 22k | $12k | 100% | Dec 2025 |
|
| Sassicaia Capital Advisers | 16k | $1.7k | 100% | Mar 2026 |
|
Who sold out of Ropanc Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2025 | 42k | $71k |
| Two Sigma Securities | Dec 2025 | 26k | $14k |
| Two Sigma Investments | Dec 2025 | 16k | $8.7k |